|
 |
Volume 5, Number 5 (May 2008) | |||||||||||||||||
Letter from the Editor |
|||||||||||||||||
218 |
The long path from Petri dish to patient The West Clinic, Memphis, TN At an increasing pace, researchers are finding more cancer cell mechanisms to target. In community oncology clinics, the task is to organize delivery of this ever-improving care, the focus of several articles in our current issue.
|
||||||||||||||||
Community Dialogue |
|||||||||||||||||
225 |
There will be blood: ESA restrictions, transfusions, and cancer patients ESAs are now restricted, the need for transfusions is rising, and a recent report in the New England Journal of Medicine raised concerns about using "old" versus "new" blood. For insight, we spoke with an expert in blood banks and transfusions.
| ||||||||||||||||
Community Translations |
|||||||||||||||||
229 |
Totect (dexrazoxane) for treatment of anthracycline extravasation Traditionally, when a vesicant agent being administered by IV leaked out into a vein, nurses could only treat this painful and damaging extravasation with warm or cold compresses. Now, the FDA has approved dexrazoxane hydrochloride for injection (Totect) to manage extravasation. | ||||||||||||||||
FROM THE ADMINISTRATOR'S PERSPECTIVE Manager, Cancer Services, Carson Tahoe Cancer Center, Carson City, NV
| |||||||||||||||||
Controversies in Patient Care |
|||||||||||||||||
236 |
Radiation therapy for cutaneous melanoma: 2008 update University of Virginia Medical School, Charlottesville, VA The incidence of melanoma is increasing. Historically, melanoma has been characterized as a radiation-resistant tumor. The author discusses recommendations for radiation treatment.
| ||||||||||||||||
|
|||||||||||||||||
Economics/Practice Management |
|||||||||||||||||
245 |
Practice–hospital partnerships: a marriage made for patients University of Virginia Medical School, Charlottesville, VA When New Hampshire Oncology Hematology partnered with Dana-Farber Cancer Institute, the result was a strengthened private practice able to offer more to its patients while retaining its grassroots culture.
| ||||||||||||||||
Nursing Management |
|||||||||||||||||
250 |
Safeguarding patients and avoiding medical errors in chemotherapy infusion suites Palmetto Hematology Oncology, PA, Gibbs Cancer Center, Spartanburg, SC Providing safety to patients in chemotherapy infusion suites can be accomplished with a systematic approach: spelling out tasks with specific policies and procedures, improving communication and patient and staff education, and ensuring staff safety.
| ||||||||||||||||
Challenging Cases/Rare Cancers |
|||||||||||||||||
258 |
Endometrial adenocarcinoma with idiopathic thrombocytopenic purpura treated without chemotherapy or irradiation Department of Obstetrics and Gynecology, Clinical Research Institute, Kyusyu Medical Center, Japan Idiopathic thrombocytopenic purpura (ITP) is a rare complication in patients with nonhematologic malignancies. The authors describe the occurrence of ITP in a woman with uterine endometrial cancer that resolved upon resection of the tumor.
| ||||||||||||||||
260 |
Occurrence of immune thrombocytopenic purpura in patients with nonhematologic cancers: a systematic review of clinical evidence from case reports Colleges of Medicine and Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, OK Multiple case reports have described the occurrence of idiopathic thrombocytopenia purpura (ITP) in patients with nonhematologic cancers. To evaluate the evidence for an association of these disorders unrelated to apparent etiologies for thrombocytopenia, such as treatment-related bone marrow suppression or bone marrow metastases, the authors performed a systematic review to identify and analyze all case reports.
| ||||||||||||||||
Original Contribution |
|||||||||||||||||
271 |
Implementation of sentinel node biopsy for breast cancer in a community hospital Division of Surgical Oncology, The Dewitt Daughtry Family Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL, and Department of Pathology, Ha’emek Medical Center, Afula, Israel In a well-controlled and carefully designed implementation process, an experienced surgeon can build a new collaborative team for sentinel node biopsy and can rapidly achieve very good results. | ||||||||||||||||
COMMENTARY Chief of Breast Surgery, San Antonio Community Hospital Breast Center, Upland, CA
| |||||||||||||||||
Adverse Events Alert |
|||||||||||||||||
255 |
Identifying and reporting adverse drug events in oncology Division of Hematology/Oncology, The Robert H. Lurie Comprehensive Cancer Center of Northwestern University Feinberg School of Medicine, and VA Midwest Center for the Management of Complex Chronic Care, Jesse Brown VA Medical Center, Chicago, IL Practical information on establishing, documenting, and filing a report on an adverse drug event.
| ||||||||||||||||
Technology |
|||||||||||||||||
276 |
The pocket-sized billing department If you’re not as diligent as you could be when it comes to recording office charges, a PDA can make it easy to document visits as you go.
| ||||||||||||||||
Washington Update |
|||||||||||||||||
277 |
Staying the course David H. Henry, MD, interviews Senator Arlen Specter (R-PA) on the recurrence of his Hodgkin's lymphoma, healthcare in the United States, and what the senator believes the government needs to do to protect the health of Americans.
| ||||||||||||||||
© 2008 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. |
|||||||||||||||||
42 kb